Responsibilities include collaborating with cross-functional teams to plan, develop and execute lab-related aspects of a clinical trial with minimum supervision…
From Seattle Genetics, Inc. - Wed, 18 Dec 2019 06:16:47 GMT - View all Bothell, WA jobs

If claiming veteran's preference, you must submit a DD214, Certificate of Release from Active Duty, which shows dates of service and discharge under honorable… $62,236 - $80,912 a year
From usajobs.gov - Tue, 17 Dec 2019 21:52:27 GMT - View all Madison, WI jobs

Funding Opportunity RFA-AG-21-002 from the NIH Guide for Grants and Contracts. This FOA will support research on aspects of rejuvenation and accelerated aging observed specifically in heterochronic blood exchange (HBE) experiments. The objectives are to identify the multiple factors involved, the multiple cell types involved and the mechanisms underlying rejuvenation or accelerated aging that is observed in the transfer of phenotypes between young and old laboratory animals. It is also anticipated that molecular signatures of rejuvenation or accelerated aging will be obtained from research supported under this FOA.

Funding Opportunity RFA-AG-21-010 from the NIH Guide for Grants and Contracts. Recent reports highlight the enormous spatial and temporal diversity of glia, even within the same glial cell type. This within-glial-cell-type heterogeneity evolves during aging, suggesting that subtypes of glia with distinct physiological roles could emerge to influence brain aging processes. The goal of this Funding Opportunity Announcement is to support research addressing critical knowledge gaps in our understanding of how these glial subpopulations could contribute to vulnerability and resilience to brain aging.

Funding Opportunity RFA-HD-21-013 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support innovative, multidisciplinary, interactive, and synergistic program projects that integrate basic, translational, and clinical approaches to understanding the developmental biology and genetic basis of significant congenital human malformations. To contain costs, each program project will consist of only three component research projects, as well as associated cores. At least one project must use basic research in an animal model system and at least one project must be clinical or translational in nature. The component research projects must share a common central theme, focus, or objective on a specific major developmental defect or malformation that is genotypically, mechanistically, biologically, or phenotypically analogous or homologous in both animal models and humans. Any non-mammalian or mammalian animal model may be used, as long as it contributes to the common overall theme or objective of the program project. The component research projects should share a common developmental gene, process, mechanism, pathway, or phenotype.

Notice NOT-AG-20-010 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-013 from the NIH Guide for Grants and Contracts

Competitive: CK Group: George Truman at CK Technical is recruiting for a Bioinformatics Developer to join a clinical stage, biopharmaceutical company at their site based in Cambridge on... Cambridge

Competitive: CK Group: Emily Mills at CK Technical is recruiting for a Senior Bioinformatistician to join a clinical stage, biopharmaceutical company at their site based in Cambridge on... Cambridge

£25,694 to £33,139: Wellcome Sanger Institute: Bioinformatician/Software Developer - Cancer Ageing and Somatic Mutation Grade: 3 Salary per annum £25,694 to £33,139 Full Time or Pa Hinxton, Cambridgeshire, England

£32,375 to £54,394: Wellcome Sanger Institute: Postdoctoral Fellow/Principal Bioinformatician in the Vento-Tormo Group Grade: 1 Salary per annum £32,375 to £54,394 Full Time or Part Hinxton, Cambridgeshire, England

Funding Opportunity RFA-MH-20-331 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research applications to elucidate mechanisms of neuroimmune dysfunction caused by HIV-1 and to detect persistent/latent/reactivated HIV using novel imaging/neuroimaging approaches in the central nervous system in anti-retroviral therapy (ART) suppressed individuals. ?These studies may involve considerable risk but may lead to a breakthrough or to the development of novel techniques, agents, methods, measures, models, or strategies, or to the generation of pilot or feasibility data. Basic, preclinical and clinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Funding Opportunity RFA-MH-20-330 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research applications to elucidate mechanisms of neuroimmune dysfunction caused by HIV-1 and to detect persistent/latent/reactivated HIV using novel imaging/neuroimaging approaches in the central nervous system from anti-retroviral therapy (ART) suppressed individuals. Applications testing a fully conceptualized and hypothesis-based solid premise founded with adequate preliminary data should consider applying to the companion R21 announcement, RFA MH-20-331 . Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Notice NOT-HL-19-731 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-017 from the NIH Guide for Grants and Contracts

Notice NOT-DK-20-003 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-017 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-019 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Bioinformatician A thriving young biotech specialising in drug discovery & development for critical CNS conditions is seeking an exceptional Bioinformatician with strong analysis skills to join their select team. Cambridge, England

Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England